Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014
暂无分享,去创建一个
G. Horsman | W. Demczuk | I. Martin | S. Peterson | A. Bharat | G. Van Domselaar | M. Graham | B. Lefebvre | V. Allen | L. Hoang | G. Tyrrell | J. Wylie | D. Haldane | C. Archibald | T. Wong | M. Unemo | M. Mulvey
[1] W. Shafer,et al. Decreased Azithromycin Susceptibility ofNeisseria gonorrhoeae Due to mtrRMutations , 1999, Antimicrobial Agents and Chemotherapy.
[2] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[3] L. Ng,et al. Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae , 2002, Antimicrobial Agents and Chemotherapy.
[4] W. Whittington,et al. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. , 2003, The Journal of antimicrobial chemotherapy.
[5] Douglas M. Warner,et al. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC‐MtrD‐MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness , 2008, Molecular microbiology.
[6] H. Palmer,et al. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. , 2008, The Journal of antimicrobial chemotherapy.
[7] R. Howe,et al. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. , 2009, The Journal of antimicrobial chemotherapy.
[8] P. Stefanelli,et al. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. , 2009, The Journal of antimicrobial chemotherapy.
[9] J. Vázquez,et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. , 2009, Sexually transmitted diseases.
[10] M. Unemo,et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. , 2009, The Journal of antimicrobial chemotherapy.
[11] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[12] J. Tapsall. Australian gonococcal surveillance. , 2009 .
[13] Pushkala Jayaraman,et al. A computational genomics pipeline for prokaryotic sequencing projects , 2010, Bioinform..
[14] M. Unemo,et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[15] S. Chisholm,et al. High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes , 2010, Antimicrobial Agents and Chemotherapy.
[16] O. Gascuel,et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.
[17] M. Unemo,et al. Resistance to Azithromycin of Neisseria gonorrhoeae Isolates From 2 Cities in China , 2011, Sexually transmitted diseases.
[18] M. Unemo,et al. High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure , 2011, Antimicrobial Agents and Chemotherapy.
[19] M. Unemo,et al. Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone , 2011, Antimicrobial Agents and Chemotherapy.
[20] Alexandre P. Francisco,et al. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods , 2012, BMC Bioinformatics.
[21] A Stary,et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[22] K. Sankar,et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[23] Steven Salzberg,et al. BIOINFORMATICS ORIGINAL PAPER , 2004 .
[24] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[25] M. Gilmour,et al. Emergence and Characterization of Neisseria gonorrhoeae Isolates With Decreased Susceptibilities to Ceftriaxone and Cefixime in Canada: 2001–2010 , 2012, Sexually transmitted diseases.
[26] G. Horsman,et al. Longitudinal Analysis of the Evolution and Dissemination of Neisseria gonorrhoeae Strains (Saskatchewan, Canada, 2005 to 2008) Reveals Three Major Circulating Strains and Convergent Evolution of Ciprofloxacin and Azithromycin Resistance , 2012, Journal of Clinical Microbiology.
[27] K. Holmes,et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] S. Drews,et al. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada. , 2013, Sexually transmitted diseases.
[29] I. Martin,et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. , 2013, JAMA.
[30] Samantha Lycett,et al. Automated analysis of phylogenetic clusters , 2013, BMC Bioinformatics.
[31] M. Unemo,et al. First Three Neisseria gonorrhoeae Isolates with High-Level Resistance to Azithromycin in Sweden: a Threat to Currently Available Dual-Antimicrobial Regimens for Treatment of Gonorrhea? , 2013, Antimicrobial Agents and Chemotherapy.
[32] M. Unemo,et al. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.
[33] I. Martin,et al. Azithromycin Resistance Is Coevolving with Reduced Susceptibility to Cephalosporins in Neisseria gonorrhoeae in Ontario, Canada , 2014, Antimicrobial Agents and Chemotherapy.
[34] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[35] C. del Rio,et al. Analysis of Neisseria gonorrhoeae Azithromycin Susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013 , 2014, Antimicrobial Agents and Chemotherapy.
[36] J. Bates,et al. A Neisseria gonorrhoeae strain with a meningococcal mtrR sequence. , 2014, Journal of medical microbiology.
[37] Julian Parkhill,et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study , 2014, The Lancet. Infectious diseases.
[38] G. Horsman,et al. Whole-Genome Phylogenomic Heterogeneity of Neisseria gonorrhoeae Isolates with Decreased Cephalosporin Susceptibility Collected in Canada between 1989 and 2013 , 2014, Journal of Clinical Microbiology.
[39] M. Unemo,et al. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance , 2015, BMC Infectious Diseases.
[40] Magnus Unemo,et al. Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge , 2015, BMC Infectious Diseases.
[41] M. Unemo,et al. Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland. , 2015, The Journal of antimicrobial chemotherapy.
[42] Monica Lahra. Australian Gonococcal Surveillance Programme annual report, 2013. , 2015, Communicable diseases intelligence quarterly report.
[43] J. Bates,et al. Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Australia. , 2014, The Journal of antimicrobial chemotherapy.
[44] G. Horsman,et al. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada , 2016, Emerging infectious diseases.
[45] AustrAliAn GonococcAl surveillAnce ProGrAmme AnnuAl rePort , 2022 .